News · 18 November 2026

Two drugs slow kidney decline in IgA nephropathy, final trials show

18 November 2026 · Denver, Colorado · Health · Uplifting · Science

Two drugs slow kidney decline in IgA nephropathy, final trials show
Picture: MedPage Today · MedPage Today lead image · unknown

Two drugs for IgA nephropathy, a kidney disease, slowed the loss of kidney function in final trials. The drugs, atacicept and sibeprenlimab, already had early FDA approval. Doctors shared the results at a meeting in Denver. In a trial of 431 adults, atacicept cut the risk of the disease getting worse by 76%.

Where this came from. One outlet reported this. We read it, then wrote the sixty words above.

Also on 18 November 2026